Application of autophagy in mesenchymal stem cells DOI

Min Chai,

Chunyan Zhang, Shuai Chen

et al.

World Journal of Stem Cells, Journal Year: 2024, Volume and Issue: 16(12), P. 990 - 1001

Published: Dec. 12, 2024

In this editorial, we have taken an in-depth look at the article published by Wan et al . The study showed that preconditioning mesenchymal stem cells (MSCs) protected them against programmed cell death, and increased their survival rate therapeutic potential. Autophagy, a type of is major intracellular degradation recycling pathway crucial for maintaining cellular homeostasis, self-renewal, pluripotency. We explored relationship between autophagy MSCs to determine role in applications MSCs.

Language: Английский

Omega-6 polyunsaturated fatty acids and their metabolites: a potential targeted therapy for pulmonary hypertension DOI Creative Commons
Jiayao Wang,

Shunlian Hu,

Yahan Xu

et al.

Respiratory Research, Journal Year: 2025, Volume and Issue: 26(1)

Published: March 15, 2025

Pulmonary hypertension (PH) is a progressive and life-threatening cardiopulmonary disease that not uncommon. The modulation of the pulmonary artery (PA) involves various fatty acids, including omega-6 polyunsaturated acids (ω-6 PUFAs) ω-6 PUFAs-derived oxylipins. These lipid mediators are produced through cyclooxygenase (COX), lipoxygenase (LOX), cytochrome P450 (CYP450), non-enzymatic pathways. They play crucial role in occurrence development PH by regulating function phenotype endothelial cells (PAECs), smooth muscle (PASMCs), fibroblasts, alveolar macrophages, inflammatory cells. alterations PUFAs oxylipins pivotal causing vasoconstriction, remodeling, ultimately leading to right heart failure PH. Despite limited understanding pathophysiology, there potential for novel interventions dietary pharmacological approaches targeting aim this review summarize significant advances clinical basic research on vascular disease, particularly PH, propose targeted therapeutic modality against PUFAs.

Language: Английский

Citations

1

Epigenetic regulation of programmed cell death in hypoxia-induced pulmonary arterial hypertension DOI Creative Commons
Yuan Jiang,

Shasha Song,

Jingxin Liu

et al.

Frontiers in Immunology, Journal Year: 2023, Volume and Issue: 14

Published: Sept. 11, 2023

Pulmonary arterial hypertension (PAH) is a severe progressive disease that may cause early right ventricular failure and eventual cardiac failure. The pathogenesis of PAH involves endothelial dysfunction, aberrant proliferation pulmonary artery smooth muscle cells (PASMCs), vascular fibrosis. Hypoxia has been shown to induce elevated secretion growth factor (VEGF), leading the development hypoxic PAH. However, molecular mechanisms underlying remain incompletely understood. Programmed cell death (PCD) natural regulated by certain genes. Emerging evidence suggests apoptotic resistance contributes Moreover, several novel types PCD, such as autophagy, pyroptosis, ferroptosis, have reported be involved in Additionally, multiple diverse epigenetic including RNA methylation, DNA histone modification, non-coding molecule-mediated processes strongly linked These modifications affect expression genes, which produce important changes cellular biological processes, PCD. Consequently, better understanding PCD modification will provide novel, specific therapeutic strategies for diagnosis treatment. In this review, we aim discuss recent advances elucidate role regulating hypoxia-induced

Language: Английский

Citations

14

The dual role of mesenchymal stem cells in apoptosis regulation DOI Creative Commons
Zhuo Chen, Xuewei Xia, Mengwei Yao

et al.

Cell Death and Disease, Journal Year: 2024, Volume and Issue: 15(4)

Published: April 6, 2024

Abstract Mesenchymal stem cells (MSCs) are widely distributed pluripotent with powerful immunomodulatory capacity. MSCs transplantation therapy (MSCT) is used in the fields of tissue regeneration and repair, treatment inflammatory diseases. Apoptosis an important way for tissues to maintain cell renewal, but it also plays role various And many studies have shown that improves diseases by regulating apoptosis. The regulation on apoptosis double-sided. On one hand, significantly inhibit diseased cells. other promote tumor excessive immune Furthermore, regulate through multiple molecules pathways, including three classical apoptotic signaling pathways pathways. In this review, we summarize current evidence MSCs.

Language: Английский

Citations

6

PANoptosis: Novel insight into regulated cell death and its potential role in cardiovascular diseases (Review) DOI Creative Commons
Xinyu Gao,

Cuixue Ma,

Shan Liang

et al.

International Journal of Molecular Medicine, Journal Year: 2024, Volume and Issue: 54(3)

Published: July 4, 2024

PANoptosis, a complex form of proinflammatory programmed cell death, including apoptosis, pyroptosis and necroptosis, has been an emerging concept in recent years that widely reported cancer, infectious diseases neurological disorders. Cardiovascular (CVDs) are important global health problem, posing serious threat to individuals' lives. An increasing body research shows inflammation pivotal role CVDs, which provides theoretical basis for PANoptosis promote the progression CVDs. To date, only sporadic studies on CVDs have its field not fully explored. Elucidating various modes cardiomyocyte specific molecular mechanisms links among death under stressful stimuli is notable clinical significance deeper understanding pathophysiology The present review summarizes pyroptosis, necroptosis their prospects

Language: Английский

Citations

6

Overexpression of PRDX2 in Adipose-Derived Mesenchymal Stem Cells Enhances the Therapeutic Effect in a Neurogenic Erectile Dysfunction Rat Model by Inhibiting Ferroptosis DOI Creative Commons
Peng Chen, Zehong Chen, Jiancheng Zhai

et al.

Oxidative Medicine and Cellular Longevity, Journal Year: 2023, Volume and Issue: 2023, P. 1 - 18

Published: Feb. 8, 2023

Neurogenic erectile dysfunction (NED) is a common and serious complication after pelvic surgery. The clinical translation of adipose-derived mesenchymal stem cell (ADSC) therapies in NED remains major challenge due to their low survival rate limited therapeutic effect. Peroxiredoxin 2 (PRDX2) member the peroxidase family that exerts its effects by inhibiting oxidative stress (OS) ferroptosis, PRDX2 expected enhance effect ADSCs treating NED. purpose this study was investigate whether could improve determine overexpression (PRDX2-ADSCs) This investigated potential role PRDX2-ADSCs through model induced bilateral cavernous nerve injury (BCNI) three vitro models established H2O2-stimulated ADSCs, corpus cavernosum smooth muscle cells (CCSMCs), RSL3-stimulated CCSMCs. We found significantly viability suppressing apoptosis OS ADSCs. also BCNI triggered ferroptosis cavernosum, which manifested increased reactive oxygen species (ROS), total iron content, MDA as well decreased SOD GSH. Our results further demonstrated changes expression key proteins (GPX4 ACSL4) pathway, whereas ameliorated BCNI-induced rats. Consistently, attenuated CCSMCs inhibited CCSMCs, evidenced decrease ROS, increase GSH together with ferroptosis-related protein expression. In conclusion, enhanced rat neurogenic via regulation GPX4/ACSL4 axis.

Language: Английский

Citations

10

Exploring the Potential of Stem Cells in Modulating Gut Microbiota and Managing Hypertension DOI
Asma Ismail Mahmod, Kayatri Govindaraju, Yogeswaran Lokanathan

et al.

Stem Cells and Development, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 21, 2025

Hypertension, commonly known as high blood pressure, is a significant health issue that increases the risk of cardiovascular diseases, stroke, and renal failure. This condition broadly encompasses both primary secondary forms. Despite extensive research, underlying mechanisms systemic arterial hypertension-particularly hypertension, which has no identifiable cause affected by genetic lifestyle agents-remain complex not fully understood. Recent studies indicate an imbalance in gut microbiota, referred to dysbiosis, may promote affecting pressure regulation through metabolites such short-chain fatty acids trimethylamine N-oxide. Current antihypertensive medications face limitations, including resistance adherence issues, highlighting need for novel therapeutic approaches. Stem cell therapy, emerging field regenerative medicine, shows promise addressing these challenges. cells, with mesenchymal stem cells being prime example, have regenerative, anti-inflammatory, immunomodulatory properties. Emerging research indicates can modulate reduce inflammation, improve vascular health, potentially aiding management. Research shown positive impact on microbiota various disorders, suggesting their potential role treating hypertension. review synthesizes recent interactions between By offering thorough analysis current literature, it highlights key insights, uncovers critical gaps, identifies trends will inform guide future investigations this rapidly advancing field.

Language: Английский

Citations

0

Valproic acid preconditioning of bone marrow mesenchymal stem cells promotes remyelination of the corpus callosum in a cuprizone-induced demyelination model DOI

Golaleh Noorzehi,

Parichehr Pasbakhsh, Fatemeh Taghizadeh

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2025, Volume and Issue: 186, P. 118027 - 118027

Published: April 2, 2025

Language: Английский

Citations

0

Preconditioning and post-preconditioning states of mesenchymal stem cells with deferoxamine: A Comprehensive Analysis DOI
Başak Işıldar, Serbay Ozkan,

Duygu Neccar

et al.

European Journal of Pharmacology, Journal Year: 2025, Volume and Issue: unknown, P. 177574 - 177574

Published: April 1, 2025

Language: Английский

Citations

0

Exploring hypoxia driven subtypes of pulmonary arterial hypertension through transcriptomics single cell sequencing and machine learning DOI Creative Commons

Jianghao Xiong,

Jiali Chen,

Jianjun Zhou

et al.

Scientific Reports, Journal Year: 2025, Volume and Issue: 15(1)

Published: April 24, 2025

Pulmonary arterial hypertension (PAH) is a progressive cardiovascular disease characterized by elevated pulmonary pressure, leading to right heart failure and death. Despite advancements in diagnosis treatment, it remains incurable, its mechanisms are poorly understood. This study aimed integrate multi-omics data analysis machine learning techniques uncover the molecular characteristics subtypes of PAH, providing insights into precise therapeutic strategies. We employed consensus clustering classify PAH patients subgroups based on data. Differential expression enrichment analyses were conducted identify key genes pathways. Machine models developed predict assess their diagnostic performance. divided two subgroups: C1 C2. The C2 subgroup showed significantly upregulated hypoxia-related genes, indicating distinct pathogenic mechanisms. Key associated with hypoxia, immune regulation, inflammation identified, alongside enriched pathways such as TNF, IL-17, HIF-1 subgroup. achieved high accuracy (AUC > 0.85) distinguishing hypoxia-associated subtypes, supporting utility for diagnosis. Potential targets identified TNF provides novel PAH's mechanisms, offering tools potential personalized treatment. Validation larger cohorts experimental studies essential confirm biomarkers

Language: Английский

Citations

0

Poly-ε-caprolactone/chitosan/whitlockite electrospun bionic membrane conjugated with an E7 peptide for bone regeneration DOI Creative Commons
Guangzi Chen, Tao Xu, Ran Gao

et al.

Stem Cell Research & Therapy, Journal Year: 2025, Volume and Issue: 16(1)

Published: April 28, 2025

Language: Английский

Citations

0